JP6503342B2 - ヒト起源ｅｇｆドメインタンパク質及びその使用 - Google Patents

ヒト起源ｅｇｆドメインタンパク質及びその使用 Download PDF

Info

Publication number
JP6503342B2
JP6503342B2 JP2016515625A JP2016515625A JP6503342B2 JP 6503342 B2 JP6503342 B2 JP 6503342B2 JP 2016515625 A JP2016515625 A JP 2016515625A JP 2016515625 A JP2016515625 A JP 2016515625A JP 6503342 B2 JP6503342 B2 JP 6503342B2
Authority
JP
Japan
Prior art keywords
seq
protein
egf1
rfp
vii
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
JP2016515625A
Other languages
English (en)
Japanese (ja)
Other versions
JP2016520599A (ja
JP2016520599A5 (enExample
Inventor
シュー ソン
シュー ソン
リン リー
リン リー
ジンウー チェン
ジンウー チェン
デンジャオ マー
デンジャオ マー
Original Assignee
チョントゥー ソースバイオ リミテッド ライアビリティ カンパニー
チョントゥー ソースバイオ リミテッド ライアビリティ カンパニー
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by チョントゥー ソースバイオ リミテッド ライアビリティ カンパニー, チョントゥー ソースバイオ リミテッド ライアビリティ カンパニー filed Critical チョントゥー ソースバイオ リミテッド ライアビリティ カンパニー
Publication of JP2016520599A publication Critical patent/JP2016520599A/ja
Publication of JP2016520599A5 publication Critical patent/JP2016520599A5/ja
Application granted granted Critical
Publication of JP6503342B2 publication Critical patent/JP6503342B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/18—Growth factors; Growth regulators
    • A61K38/1808—Epidermal growth factor [EGF] urogastrone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/36—Blood coagulation or fibrinolysis factors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/475—Growth factors; Growth regulators
    • C07K14/485—Epidermal growth factor [EGF], i.e. urogastrone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Organic Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Toxicology (AREA)
  • Hematology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
JP2016515625A 2013-05-29 2014-05-19 ヒト起源ｅｇｆドメインタンパク質及びその使用 Active JP6503342B2 (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
CN201310206726.6 2013-05-29
CN201310206726 2013-05-29
CN201410182727.6 2014-04-30
CN201410182727.6A CN104211799B (zh) 2013-05-29 2014-04-30 人源egf结构域蛋白及其应用
PCT/CN2014/077789 WO2014190860A1 (zh) 2013-05-29 2014-05-19 人源egf结构域蛋白及其应用

Publications (3)

Publication Number Publication Date
JP2016520599A JP2016520599A (ja) 2016-07-14
JP2016520599A5 JP2016520599A5 (enExample) 2017-06-29
JP6503342B2 true JP6503342B2 (ja) 2019-04-17

Family

ID=51987987

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2016515625A Active JP6503342B2 (ja) 2013-05-29 2014-05-19 ヒト起源ｅｇｆドメインタンパク質及びその使用

Country Status (5)

Country Link
US (1) US9833497B2 (enExample)
EP (1) EP3006460B1 (enExample)
JP (1) JP6503342B2 (enExample)
CN (2) CN104211799B (enExample)
WO (1) WO2014190860A1 (enExample)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20160126075A (ko) * 2014-02-28 2016-11-01 쓰리비 파마슈티컬스 게엠베하 펩티드 및 사용 방법
US10550163B2 (en) 2014-04-03 2020-02-04 The Regents Of The University Of California Peptide fragments of netrin-1 and compositions and methods thereof
US11319343B2 (en) * 2017-06-30 2022-05-03 Royal Melbourne Institute Of Technology Method of treatment
AR121035A1 (es) 2019-04-01 2022-04-13 Lilly Co Eli Compuestos de neuregulina-4 y métodos de uso
WO2022217037A1 (en) * 2021-04-09 2022-10-13 Board Of Regents, The University Of Texas System Compositions and methods for treatment of chronic lung diseases
EP4198045A1 (en) * 2021-12-16 2023-06-21 Université de Lille Antimicrobial peptides, variants and chemical analogues thereof and their uses

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002102319A2 (en) * 2001-06-14 2002-12-27 Bristol-Myers Squibb Company Polynucleotide encoding a novel human growth factor with homology to epidermal growth factor, bgs-8, expressed highly in immune tissue
WO2004108763A2 (en) * 2003-06-05 2004-12-16 Canadian Blood Services Mutants of the factor vii epidermal growth factor domain
CA2566292A1 (en) * 2004-05-13 2005-11-24 Regents Of The University Of Minnesota Mucin3 egf-like domains
WO2009137837A2 (en) * 2008-05-09 2009-11-12 The Regents Of The University Of California Neuregulin/erbb signaling and integrin
WO2010006136A2 (en) * 2008-07-09 2010-01-14 Mayo Foundation For Medical Education And Research Adenovirus targeting
AU2010266065B2 (en) * 2009-06-25 2016-01-14 The University Of North Carolina At Chapel Hill Chimeric Factor VII molecules
PT2591006T (pt) * 2010-07-09 2019-07-29 Bioverativ Therapeutics Inc Moléculas de cadeia simples processáveis e polipéptidos preparados utilizando as mesmas

Also Published As

Publication number Publication date
EP3006460A1 (en) 2016-04-13
WO2014190860A1 (zh) 2014-12-04
EP3006460B1 (en) 2020-08-26
JP2016520599A (ja) 2016-07-14
CN105683216B (zh) 2021-03-26
US9833497B2 (en) 2017-12-05
EP3006460A4 (en) 2017-05-10
US20160184396A1 (en) 2016-06-30
CN105683216A (zh) 2016-06-15
CN104211799B (zh) 2017-12-26
CN104211799A (zh) 2014-12-17

Similar Documents

Publication Publication Date Title
Zeng et al. Identification and functional characterization of novel scorpion venom peptides with no disulfide bridge from Buthus martensii Karsch
Li et al. Preliminary study on a potential antibacterial peptide derived from histone H2A in hemocytes of scallop Chlamys farreri
Bridle et al. Evidence of an antimicrobial-immunomodulatory role of Atlantic salmon cathelicidins during infection with Yersinia ruckeri
KR20230057487A (ko) 게놈 조정을 위한 방법 및 조성물
Muncaster et al. Antimicrobial peptides within the Yellowtail Kingfish (Seriola lalandi)
KR20200116933A (ko) 인간 심근세포에서 디스트로핀 돌연변이를 교정하기 위한 조성물 및 방법
JP2016520599A (ja) ヒト起源ｅｇｆドメインタンパク質及びその使用
González et al. Molecular characterization and protein localization of the antimicrobial peptide big defensin from the scallop Argopecten purpuratus after Vibrio splendidus challenge
EP3630979A2 (en) Genetic systems that defend against foreign dna and uses thereof
JP2024063082A (ja) 皮膚疾患の治療のための組成物及び方法
WO2025251550A1 (zh) 具有广谱裂解活性的肽聚糖水解酶LysPH1及其突变体和应用
CN102212539B (zh) 高效表达的串联猪α、γ干扰素基因及其表达蛋白的用途
Zhang et al. Macrophage migration inhibitory factor (MIF) of golden pompano (Trachinotus ovatus) is involved in the antibacterial immune response
CN110592057B (zh) 嵌合裂解酶ILTphg和编码此酶的多核苷酸
CN103113461B (zh) 一种新型防御素bd2及其基因和应用
AU2003260224A2 (en) A genomic approach to identification of novel broad-spectrum antimicrobial peptides from bony fish
Yang et al. Induction of antimicrobial peptides from Rana dybowskii under Rana grylio virus stress, and bioactivity analysis
CN112480227B (zh) 一种提高鲟鱼抵抗病原菌能力的蛋白及其制备方法与应用
JP6441906B2 (ja) ヒト凝固因子軽鎖タンパク質及びその使用
CN113201061B (zh) 中华绒螯蟹肿瘤坏死因子及其应用
CN103864916B (zh) 人胸腺肽β4三倍体蛋白、编码基因及其分离纯化方法
CN104946658B (zh) 抗牛支原体蛋白Md‑UF1
CN102433341A (zh) 一种斜带石斑鱼抗菌肽的原核表达产物及其制备方法
Zhou et al. Anti-Vibrio Response of CarcininPm 1 from Penaeus monodon and Its Heterologous Expression
CN109055411B (zh) 抑制WSSV增殖的半胱天冬氨酸酶基因Cq-caspase及其蛋白抗病毒活性应用

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20170519

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20170519

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20180205

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20180502

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20180730

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20181030

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20181228

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20190110

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20190228

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20190325

R150 Certificate of patent or registration of utility model

Ref document number: 6503342

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250